SPATA18 and cancer: [9] On the basis of Spata18-deficient mice models, tumor suppressive effects of SPATA18 were suggested; inactivation of SPATA18-regulated mitochondrial quality control leads to accumulation of unhealthy mitochondria and increased mitochondrial ROS (reactive oxygen species) generation, which probably promotes cancer development and aggressiveness [9,10].